C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer’s disease ; volume:10 ; number:1 ; day:17 ; month:8 ; year:2022 ; pages:1-21 ; date:12.2022
Acta Neuropathologica Communications ; 10, Heft 1 (17.8.2022), 1-21, 12.2022
- Urheber
-
Gomez-Arboledas, Angela
Carvalho, Klebea
Balderrama-Gutierrez, Gabriela
Chu, Shu-Hui
Liang, Heidi Yahan
Schartz, Nicole D.
Selvan, Purnika
Petrisko, Tiffany J.
Pan, Miranda A.
Mortazavi, Ali
Tenner, Andrea J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-022-01416-6
- URN
-
urn:nbn:de:101:1-2022110420094285477899
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gomez-Arboledas, Angela
- Carvalho, Klebea
- Balderrama-Gutierrez, Gabriela
- Chu, Shu-Hui
- Liang, Heidi Yahan
- Schartz, Nicole D.
- Selvan, Purnika
- Petrisko, Tiffany J.
- Pan, Miranda A.
- Mortazavi, Ali
- Tenner, Andrea J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer’s disease mouse model
Alzheimer’s Disease
CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
Alzheimer's disease
Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and Alzheimer’s disease-like neuroinflammation triggered by periodontal disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Cerebrovascular disease in ageing and Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer’s disease mouse model
Alzheimer’s Disease
CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
Alzheimer's disease
Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and Alzheimer’s disease-like neuroinflammation triggered by periodontal disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Cerebrovascular disease in ageing and Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease
Treatments in Alzheimer’s disease
C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer’s disease mouse model
Alzheimer’s Disease
CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
Alzheimer's disease
Nisin a probiotic bacteriocin mitigates brain microbiome dysbiosis and Alzheimer’s disease-like neuroinflammation triggered by periodontal disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Cerebrovascular disease in ageing and Alzheimer’s disease
Endocytosis and Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Genetics of Alzheimer’s disease